Sii Investments Inc. WI Purchases 68 Shares of Medtronic PLC (NYSE:MDT)
Sii Investments Inc. WI increased its stake in shares of Medtronic PLC (NYSE:MDT) by 1.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,772 shares of the medical technology company’s stock after buying an additional 68 shares during the period. Sii Investments Inc. WI’s holdings in Medtronic PLC were worth $464,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of MDT. Oppenheimer Asset Management Inc. bought a new stake in shares of Medtronic PLC during the first quarter valued at $4,708,000. Edmond DE Rothschild Holding S.A. boosted its stake in shares of Medtronic PLC by 2.0% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 174,632 shares of the medical technology company’s stock valued at $14,069,000 after buying an additional 3,405 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of Medtronic PLC by 3.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 4,370,566 shares of the medical technology company’s stock valued at $352,093,000 after buying an additional 142,729 shares in the last quarter. Capital Investment Counsel Inc bought a new stake in shares of Medtronic PLC during the first quarter valued at $203,000. Finally, Amalgamated Bank boosted its stake in shares of Medtronic PLC by 6.2% in the first quarter. Amalgamated Bank now owns 98,177 shares of the medical technology company’s stock valued at $7,909,000 after buying an additional 5,700 shares in the last quarter. Institutional investors own 83.36% of the company’s stock.
Medtronic PLC (NYSE:MDT) traded up 1.00% on Friday, hitting $83.87. The stock had a trading volume of 1,609,016 shares. The firm has a market capitalization of $113.98 billion, a price-to-earnings ratio of 29.02 and a beta of 1.02. Medtronic PLC has a 1-year low of $69.35 and a 1-year high of $89.72. The stock’s 50-day moving average is $86.33 and its 200 day moving average is $82.81.
Medtronic PLC (NYSE:MDT) last announced its quarterly earnings results on Thursday, May 25th. The medical technology company reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. The firm had revenue of $7.92 billion during the quarter, compared to analyst estimates of $7.86 billion. Medtronic PLC had a return on equity of 12.72% and a net margin of 13.56%. Medtronic PLC’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.27 earnings per share. On average, equities research analysts predict that Medtronic PLC will post $4.81 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Investors of record on Friday, July 7th were issued a $0.46 dividend. This is a positive change from Medtronic PLC’s previous quarterly dividend of $0.43. The ex-dividend date was Wednesday, July 5th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.22%. Medtronic PLC’s payout ratio is presently 63.67%.
ILLEGAL ACTIVITY WARNING: This piece of content was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of international copyright laws. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/11/sii-investments-inc-wi-purchases-68-shares-of-medtronic-plc-nysemdt.html.
Several equities research analysts recently weighed in on the company. BidaskClub upgraded Medtronic PLC from a “sell” rating to a “hold” rating in a report on Friday. Jefferies Group LLC restated a “buy” rating and set a $103.00 target price on shares of Medtronic PLC in a report on Thursday, August 3rd. Zacks Investment Research cut Medtronic PLC from a “hold” rating to a “sell” rating in a report on Monday, July 31st. Deutsche Bank AG set a $96.00 target price on Medtronic PLC and gave the company a “buy” rating in a report on Monday, July 31st. Finally, Oppenheimer Holdings, Inc. restated a “buy” rating on shares of Medtronic PLC in a report on Tuesday, July 18th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and fifteen have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $89.84.
In related news, EVP Bryan C. Hanson sold 12,000 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $88.57, for a total value of $1,062,840.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard H. Anderson purchased 5,600 shares of the stock in a transaction that occurred on Wednesday, June 21st. The stock was purchased at an average price of $88.90 per share, with a total value of $497,840.00. Following the acquisition, the director now directly owns 71,910 shares of the company’s stock, valued at approximately $6,392,799. The disclosure for this purchase can be found here. 0.25% of the stock is currently owned by insiders.
About Medtronic PLC
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).
Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.